Elicio Therapeutics, Inc. (ELTX)

SEC filing

Elicio Therapeutics, Inc.

ELTX · CIK 1601485

4 · Sep 2, 2026 · Director Venkatesan Jay was granted 21.75K Stock Option (Right to Buy)

Director Venkatesan Jay was granted 21.75K Stock Option (Right to Buy)

FORM 4

xslF345X06/wk-form4_1788379344.xmlSEC.gov

elicio-powerofattorneyve.htm

elicio-powerofattorneyve.htmSEC.gov

Graphics and non-inline formats (not embedded below).